Selected research
Market Analysis & Forecast
Global Hospital Infection Management System Market Analysis and Forecast 2026-2032
Market perspective
The global Hospital Infection Management System market is projected to grow from US$ million in 2026 to US$ million by 2032, at a Compound Annual Growth Rate (CAGR) of % during the forecast period.
The North America market for Hospital Infection Management System is estimated to increase from $ million in 2026 to reach $ million by 2032, at a CAGR of % during the forecast period of 2026 through 2032.
Europe market for Hospital Infection Management System is estimated to increase from $ million in 2026 to reach $ million by 2032, at a CAGR of % during the forecast period of 2026 through 2032.
Read the full market overview
Asia-Pacific market for Hospital Infection Management System is estimated to increase from $ million in 2026 to reach $ million by 2032, at a CAGR of % during the forecast period of 2026 through 2032.
The China market for Hospital Infection Management System is estimated to increase from $ million in 2026 to reach $ million by 2032, at a CAGR of % during the forecast period of 2026 through 2032.
The major global companies of Hospital Infection Management System include Laoken Medical, STERIS, DNV, Huawei, Dräger, Ecolab, Yinjiang Technology, Yi Ou Technology and Zexin Software, etc. In 2025, the world's top three vendors accounted for approximately % of the revenue.
Report Includes
This report presents an overview of global market for Hospital Infection Management System, market size. Analyses of the global market trends, with historic market revenue data for 2021 - 2025, estimates for 2026, and projections of CAGR through 2032.
This report researches the key producers of Hospital Infection Management System, also provides the revenue of main regions and countries. Of the upcoming market potential for Hospital Infection Management System, and key regions or countries of focus to forecast this market into various segments and sub-segments. Country specific data and market value analysis for the U.S., Canada, Mexico, Brazil, China, Japan, South Korea, Southeast Asia, India, Germany, the U.K., Italy, Middle East, Africa, and Other Countries.
This report focuses on the Hospital Infection Management System revenue, market share and industry ranking of main manufacturers, data from 2021 to 2026. Identification of the major stakeholders in the global Hospital Infection Management System market, and analysis of their competitive landscape and market positioning based on recent developments and segmental revenues. This report will help stakeholders to understand the competitive landscape and gain more insights and position their businesses and market strategies in a better way.
This report analyzes the segments data by Type and by Application, revenue, and growth rate, from 2021 to 2032. Evaluation and forecast the market size for Hospital Infection Management System revenue, projected growth trends, production technology, application and end-user industry.
Hospital Infection Management System Segment by Company
Laoken Medical
STERIS
DNV
Huawei
Dräger
Ecolab
Yinjiang Technology
Yi Ou Technology
Zexin Software
Siyunshan Technology
Ganxin Information Technology
Peking University Medical Information Technology
Hospital Infection Management System Segment by Type
Endogenous Infection Type
Exogenous Infectious Type
Hospital Infection Management System Segment by Application
Public Hospital
Private Hospital
Hospital Infection Management System Segment by Region
North America
United States
Canada
Mexico
Europe
Germany
France
U.K.
Italy
Russia
Spain
Netherlands
Switzerland
Sweden
Poland
Asia-Pacific
China
Japan
South Korea
India
Australia
Taiwan
Southeast Asia
South America
Brazil
Argentina
Chile
Colombia
Middle East & Africa
Egypt
South Africa
Israel
Türkiye
GCC Countries
Study Objectives
1. To analyze and research the global status and future forecast, involving growth rate (CAGR), market share, historical and forecast.
2. To present the key players, revenue, market share, and Recent Developments.
3. To split the breakdown data by regions, type, manufacturers, and Application.
4. To analyze the global and key regions market potential and advantage, opportunity and challenge, restraints, and risks.
5. To identify significant trends, drivers, influence factors in global and regions.
6. To analyze competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.
Reasons to Buy This Report
1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Hospital Infection Management System market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.
2. This report will help stakeholders to understand the global industry status and trends of Hospital Infection Management System and provides them with information on key market drivers, restraints, challenges, and opportunities.
3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in market size), competitor ecosystem, new product development, expansion, and acquisition.
4. This report stays updated with novel technology integration, features, and the latest developments in the market.
5. This report helps stakeholders to gain insights into which regions to target globally.
6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Hospital Infection Management System.
7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.
Chapter Outline
Chapter 1: Introduces the report scope of the report, executive summary of different market segments (product type, application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 3: Revenue of Hospital Infection Management System in global and regional level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.
Chapter 4: Detailed analysis of Hospital Infection Management System company competitive landscape, revenue, market share and industry ranking, latest development plan, merger, and acquisition information, etc.
Chapter 5: Provides the analysis of various market segments by type, covering the revenue, and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 6: Provides the analysis of various market segments by application, covering the revenue, and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 7: Provides profiles of key companies, introducing the basic situation of the main companies in the market in detail, including product descriptions and specifications, Hospital Infection Management System revenue, gross margin, and recent development, etc.
Chapter 8: North America by type, by application and by country, revenue for each segment.
Chapter 9: Europe by type, by application and by country, revenue for each segment.
Chapter 10: China type, by application, revenue for each segment.
Chapter 11: Asia (excluding China) type, by application and by region, revenue for each segment.
Chapter 12: South America, Middle East and Africa by type, by application and by country, revenue for each segment.
Chapter 13: The main concluding insights of the report.
More report detail
Tables and figures
Scope & coverage.
Types
- Endogenous Infection Type
- Exogenous Infectious Type
Applications
- Public Hospital
- Private Hospital
Companies covered
- Laoken Medical
- STERIS
- DNV
- Huawei
- Dräger
- Ecolab
- Yinjiang Technology
- Yi Ou Technology
- Zexin Software
- Siyunshan Technology
- Ganxin Information Technology
- Peking University Medical Information Technology
Inside the report.
1 Market Overview
- 1.1 Product Definition
- 1.2 Hospital Infection Management System Market by Type
- 1.2.1 Global Hospital Infection Management System Market Size by Type, 2021 VS 2025 VS 2032
- 1.2.2 Endogenous Infection Type
- 1.2.3 Exogenous Infectious Type
- 1.3 Hospital Infection Management System Market by Application
- 1.3.1 Global Hospital Infection Management System Market Size by Application, 2021 VS 2025 VS 2032
- 1.3.2 Public Hospital
- 1.3.3 Private Hospital
- 1.4 Assumptions and Limitations
- 1.5 Study Goals and Objectives
2 Hospital Infection Management System Market Dynamics
- 2.1 Hospital Infection Management System Industry Trends
- 2.2 Hospital Infection Management System Industry Drivers
- 2.3 Hospital Infection Management System Industry Opportunities and Challenges
- 2.4 Hospital Infection Management System Industry Restraints
3 Global Growth Perspective
- 3.1 Global Hospital Infection Management System Market Perspective (2021-2032)
- 3.2 Global Hospital Infection Management System Growth Trends by Region
- 3.2.1 Global Hospital Infection Management System Market Size by Region: 2021 VS 2025 VS 2032
- 3.2.2 Global Hospital Infection Management System Market Size by Region (2021-2026)
- 3.2.3 Global Hospital Infection Management System Market Size by Region (2027-2032)
4 Competitive Landscape by Players
- 4.1 Global Hospital Infection Management System Revenue by Players
- 4.1.1 Global Hospital Infection Management System Revenue by Players (2021-2026)
- 4.1.2 Global Hospital Infection Management System Revenue Market Share by Players (2021-2026)
- 4.1.3 Global Hospital Infection Management System Players Revenue Share Top 10 and Top 5 in 2025
- 4.2 Global Hospital Infection Management System Key Players Ranking, 2024 VS 2025 VS 2026
- 4.3 Global Hospital Infection Management System Key Players Headquarters & Area Served
- 4.4 Global Hospital Infection Management System Players, Product Type & Application
- 4.5 Global Hospital Infection Management System Players Establishment Date
- 4.6 Market Competitive Analysis
- 4.6.1 Global Hospital Infection Management System Market CR5 and HHI
- 4.6.3 2025 Hospital Infection Management System Tier 1, Tier 2, and Tier 3
5 Hospital Infection Management System Market Size by Type
- 5.1 Global Hospital Infection Management System Revenue by Type (2021 VS 2025 VS 2032)
- 5.2 Global Hospital Infection Management System Revenue by Type (2021-2032)
- 5.3 Global Hospital Infection Management System Revenue Market Share by Type (2021-2032)
6 Hospital Infection Management System Market Size by Application
- 6.1 Global Hospital Infection Management System Revenue by Application (2021 VS 2025 VS 2032)
- 6.2 Global Hospital Infection Management System Revenue by Application (2021-2032)
- 6.3 Global Hospital Infection Management System Revenue Market Share by Application (2021-2032)
7 Company Profiles
- 7.1 Laoken Medical
- 7.1.1 Laoken Medical Company Information
- 7.1.2 Laoken Medical Business Overview
- 7.1.3 Laoken Medical Hospital Infection Management System Revenue and Gross Margin (2021-2026)
- 7.1.4 Laoken Medical Hospital Infection Management System Product Portfolio
- 7.1.5 Laoken Medical Recent Developments
- 7.2 STERIS
- 7.2.1 STERIS Company Information
- 7.2.2 STERIS Business Overview
- 7.2.3 STERIS Hospital Infection Management System Revenue and Gross Margin (2021-2026)
- 7.2.4 STERIS Hospital Infection Management System Product Portfolio
- 7.2.5 STERIS Recent Developments
- 7.3 DNV
- 7.3.1 DNV Company Information
- 7.3.2 DNV Business Overview
- 7.3.3 DNV Hospital Infection Management System Revenue and Gross Margin (2021-2026)
- 7.3.4 DNV Hospital Infection Management System Product Portfolio
- 7.3.5 DNV Recent Developments
- 7.4 Huawei
- 7.4.1 Huawei Company Information
- 7.4.2 Huawei Business Overview
- 7.4.3 Huawei Hospital Infection Management System Revenue and Gross Margin (2021-2026)
- 7.4.4 Huawei Hospital Infection Management System Product Portfolio
- 7.4.5 Huawei Recent Developments
- 7.5 Dräger
- 7.5.1 Dräger Company Information
- 7.5.2 Dräger Business Overview
- 7.5.3 Dräger Hospital Infection Management System Revenue and Gross Margin (2021-2026)
- 7.5.4 Dräger Hospital Infection Management System Product Portfolio
- 7.5.5 Dräger Recent Developments
- 7.6 Ecolab
- 7.6.1 Ecolab Company Information
- 7.6.2 Ecolab Business Overview
- 7.6.3 Ecolab Hospital Infection Management System Revenue and Gross Margin (2021-2026)
- 7.6.4 Ecolab Hospital Infection Management System Product Portfolio
- 7.6.5 Ecolab Recent Developments
- 7.7 Yinjiang Technology
- 7.7.1 Yinjiang Technology Company Information
- 7.7.2 Yinjiang Technology Business Overview
- 7.7.3 Yinjiang Technology Hospital Infection Management System Revenue and Gross Margin (2021-2026)
- 7.7.4 Yinjiang Technology Hospital Infection Management System Product Portfolio
- 7.7.5 Yinjiang Technology Recent Developments
- 7.8 Yi Ou Technology
- 7.8.1 Yi Ou Technology Company Information
- 7.8.2 Yi Ou Technology Business Overview
- 7.8.3 Yi Ou Technology Hospital Infection Management System Revenue and Gross Margin (2021-2026)
- 7.8.4 Yi Ou Technology Hospital Infection Management System Product Portfolio
- 7.8.5 Yi Ou Technology Recent Developments
- 7.9 Zexin Software
- 7.9.1 Zexin Software Company Information
- 7.9.2 Zexin Software Business Overview
- 7.9.3 Zexin Software Hospital Infection Management System Revenue and Gross Margin (2021-2026)
- 7.9.4 Zexin Software Hospital Infection Management System Product Portfolio
- 7.9.5 Zexin Software Recent Developments
- 7.10 Siyunshan Technology
- 7.10.1 Siyunshan Technology Company Information
- 7.10.2 Siyunshan Technology Business Overview
- 7.10.3 Siyunshan Technology Hospital Infection Management System Revenue and Gross Margin (2021-2026)
- 7.10.4 Siyunshan Technology Hospital Infection Management System Product Portfolio
- 7.10.5 Siyunshan Technology Recent Developments
- 7.11 Ganxin Information Technology
- 7.11.1 Ganxin Information Technology Company Information
- 7.11.2 Ganxin Information Technology Business Overview
- 7.11.3 Ganxin Information Technology Hospital Infection Management System Revenue and Gross Margin (2021-2026)
- 7.11.4 Ganxin Information Technology Hospital Infection Management System Product Portfolio
- 7.11.5 Ganxin Information Technology Recent Developments
- 7.12 Peking University Medical Information Technology
- 7.12.1 Peking University Medical Information Technology Company Information
- 7.12.2 Peking University Medical Information Technology Business Overview
- 7.12.3 Peking University Medical Information Technology Hospital Infection Management System Revenue and Gross Margin (2021-2026)
- 7.12.4 Peking University Medical Information Technology Hospital Infection Management System Product Portfolio
- 7.12.5 Peking University Medical Information Technology Recent Developments
8 North America
- 8.1 North America Hospital Infection Management System Revenue (2021-2032)
- 8.2 North America Hospital Infection Management System Revenue by Type (2021-2032)
- 8.2.1 North America Hospital Infection Management System Revenue by Type (2021-2026)
- 8.2.2 North America Hospital Infection Management System Revenue by Type (2027-2032)
- 8.3 North America Hospital Infection Management System Revenue Share by Type (2021-2032)
- 8.4 North America Hospital Infection Management System Revenue by Application (2021-2032)
- 8.4.1 North America Hospital Infection Management System Revenue by Application (2021-2026)
- 8.4.2 North America Hospital Infection Management System Revenue by Application (2027-2032)
- 8.5 North America Hospital Infection Management System Revenue Share by Application (2021-2032)
- 8.6 North America Hospital Infection Management System Revenue by Country
- 8.6.1 North America Hospital Infection Management System Revenue by Country (2021 VS 2025 VS 2032)
- 8.6.2 North America Hospital Infection Management System Revenue by Country (2021-2026)
- 8.6.3 North America Hospital Infection Management System Revenue by Country (2027-2032)
- 8.6.4 United States
- 8.6.5 Canada
- 8.6.6 Mexico
9 Europe
- 9.1 Europe Hospital Infection Management System Revenue (2021-2032)
- 9.2 Europe Hospital Infection Management System Revenue by Type (2021-2032)
- 9.2.1 Europe Hospital Infection Management System Revenue by Type (2021-2026)
- 9.2.2 Europe Hospital Infection Management System Revenue by Type (2027-2032)
- 9.3 Europe Hospital Infection Management System Revenue Share by Type (2021-2032)
- 9.4 Europe Hospital Infection Management System Revenue by Application (2021-2032)
- 9.4.1 Europe Hospital Infection Management System Revenue by Application (2021-2026)
- 9.4.2 Europe Hospital Infection Management System Revenue by Application (2027-2032)
- 9.5 Europe Hospital Infection Management System Revenue Share by Application (2021-2032)
- 9.6 Europe Hospital Infection Management System Revenue by Country
- 9.6.1 Europe Hospital Infection Management System Revenue by Country (2021 VS 2025 VS 2032)
- 9.6.2 Europe Hospital Infection Management System Revenue by Country (2021-2026)
- 9.6.3 Europe Hospital Infection Management System Revenue by Country (2027-2032)
- 9.6.4 Germany
- 9.6.5 France
- 9.6.6 U.K.
- 9.6.7 Italy
- 9.6.8 Russia
- 9.6.9 Spain
- 9.6.10 Netherlands
- 9.6.11 Switzerland
- 9.6.12 Sweden
- 9.6.13 Poland
10 China
- 10.1 China Hospital Infection Management System Revenue (2021-2032)
- 10.2 China Hospital Infection Management System Revenue by Type (2021-2032)
- 10.2.1 China Hospital Infection Management System Revenue by Type (2021-2026)
- 10.2.2 China Hospital Infection Management System Revenue by Type (2027-2032)
- 10.3 China Hospital Infection Management System Revenue Share by Type (2021-2032)
- 10.4 China Hospital Infection Management System Revenue by Application (2021-2032)
- 10.4.1 China Hospital Infection Management System Revenue by Application (2021-2026)
- 10.4.2 China Hospital Infection Management System Revenue by Application (2027-2032)
- 10.5 China Hospital Infection Management System Revenue Share by Application (2021-2032)
11 Asia (Excluding China)
- 11.1 Asia Hospital Infection Management System Revenue (2021-2032)
- 11.2 Asia Hospital Infection Management System Revenue by Type (2021-2032)
- 11.2.1 Asia Hospital Infection Management System Revenue by Type (2021-2026)
- 11.2.2 Asia Hospital Infection Management System Revenue by Type (2027-2032)
- 11.3 Asia Hospital Infection Management System Revenue Share by Type (2021-2032)
- 11.4 Asia Hospital Infection Management System Revenue by Application (2021-2032)
- 11.4.1 Asia Hospital Infection Management System Revenue by Application (2021-2026)
- 11.4.2 Asia Hospital Infection Management System Revenue by Application (2027-2032)
- 11.5 Asia Hospital Infection Management System Revenue Share by Application (2021-2032)
- 11.6 Asia Hospital Infection Management System Revenue by Country
- 11.6.1 Asia Hospital Infection Management System Revenue by Country (2021 VS 2025 VS 2032)
- 11.6.2 Asia Hospital Infection Management System Revenue by Country (2021-2026)
- 11.6.3 Asia Hospital Infection Management System Revenue by Country (2027-2032)
- 11.6.4 Japan
- 11.6.5 South Korea
- 11.6.6 India
- 11.6.7 Australia
- 11.6.8 Taiwan
- 11.6.9 Southeast Asia
12 South America, Middle East and Africa
- 12.1 SAMEA Hospital Infection Management System Revenue (2021-2032)
- 12.2 SAMEA Hospital Infection Management System Revenue by Type (2021-2032)
- 12.2.1 SAMEA Hospital Infection Management System Revenue by Type (2021-2026)
- 12.2.2 SAMEA Hospital Infection Management System Revenue by Type (2027-2032)
- 12.3 SAMEA Hospital Infection Management System Revenue Share by Type (2021-2032)
- 12.4 SAMEA Hospital Infection Management System Revenue by Application (2021-2032)
- 12.4.1 SAMEA Hospital Infection Management System Revenue by Application (2021-2026)
- 12.4.2 SAMEA Hospital Infection Management System Revenue by Application (2027-2032)
- 12.5 SAMEA Hospital Infection Management System Revenue Share by Application (2021-2032)
- 12.6 SAMEA Hospital Infection Management System Revenue by Country
- 12.6.1 SAMEA Hospital Infection Management System Revenue by Country (2021 VS 2025 VS 2032)
- 12.6.2 SAMEA Hospital Infection Management System Revenue by Country (2021-2026)
- 12.6.3 SAMEA Hospital Infection Management System Revenue by Country (2027-2032)
- 12.6.4 Brazil
- 12.6.5 Argentina
- 12.6.6 Chile
- 12.6.7 Colombia
- 12.6.8 Peru
- 12.6.9 Saudi Arabia
- 12.6.10 Israel
- 12.6.11 UAE
- 12.6.12 Turkey
- 12.6.13 Iran
- 12.6.14 Egypt
13 Concluding Insights
14 Appendix
- 14.1 Reasons for Doing This Study
- 14.2 Research Methodology
- 14.3 Research Process
- 14.4 Authors List of This Report
- 14.5 Data Source
- 14.5.1 Secondary Sources
- 14.5.2 Primary Sources
GET THE RESEARCH
Choose your license.
Choose who needs access.
All options are for this report and research series.
PDF by email within 3–5 working days after payment confirmation.
Talk to an analyst